Brief: Beacon Biosignals Raises $86 Million to Accelerate AI-Driven Insights into Brain Health
13/11/2025 11:46
Nov 13 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T: BEACON BIOSIGNALS RAISES $86M TO ACCELERATE AI-DRIVEN INSIGHTS INTO BRAIN HEALTH BEACON BIOSIGNALS: FUNDING ROUND BACKED BY INNOVIVA, GOOGLE VENTURES, NEXUS NEUROTECH VENTURES, S32, TAKEDA & OTHERS Source text: nGNX15DxVz Further company coverage: 4502.T ((reuters.briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)